Appl Clin Inform 2010; 01(01): 38-49
DOI: 10.4338/ACI-2009-12-RA-0026
Research Article
Schattauer GmbH

Developing a multivariable prognostic model for pancreatic endocrine tumors using the clinical data warehouse resources of a single institution

Taxiarchis Botsis
1  Department of Biomedical Informatics, Columbia University, New York, NY, USA
2  Department of Computer Science, University of Tromsø, Norway
,
Valsamo K. Anagnostou
3  Department of Pathology, Yale University School of Medicine, New Haven, CT, USA
,
Gunnar Hartvigsen
2  Department of Computer Science, University of Tromsø, Norway
,
George Hripcsak
1  Department of Biomedical Informatics, Columbia University, New York, NY, USA
,
Chunhua Weng
1  Department of Biomedical Informatics, Columbia University, New York, NY, USA
› Author Affiliations
Further Information

Publication History

received: 23 December 2009

accepted: 10 March 2010

Publication Date:
16 December 2017 (online)

Summary

Objective: Current staging systems are not accurate for classifying pancreatic endocrine tumors (PETs) by risk. Here, we developed a prognostic model for PETs and compared it to the WHO classification system.

Methods: We identified 98 patients diagnosed with PET at NewYork-Presbyterian Hospital/Columbia University Medical Center (1999 to 2009). Tumor and clinical characteristics were retrieved and associations with survival were assessed by univariate Cox analysis. A multivariable model was constructed and a risk score was calculated; the prognostic strength of our model was assessed with the concordance index.

Results: Our cohort had median age of 60 years and consisted of 61.2% women; median follow-up time was 10.4 months (range: 0.1-99.6) with a 5-year survival of 61.5%. The majority of PETs were non-functional and no difference was observed between functional and non-functional tumors with respect to WHO stage, age, pathologic characteristics or survival. Distant metastases, aspartate aminotransferase-AST and surgical resection (HR=3.39, 95% CI: 1.38-8.35, p=0.008, HR=3.73, 95% CI: 1.20-11.57, p=0.023 and HR=0.20, 95% CI: 0.08-0.51, p<0.001 respectively) were the strongest predictors in the univariate analysis. Age, perineural and/or lymphovascular invasion, distant metastases and AST were the independent prognostic factors in the final multivariable model; a risk score was calculated and classified patients into low (n=40), intermediate (n=48) and high risk (n=10) groups. The concordance index of our model was 0.93 compared to 0.72 for the WHO system.

Conclusion: Our prognostic model was highly accurate in stratifying patients by risk; novel approaches as such could thus be incorporated into clinical decisions.